Véronique Quilien et al., P06.13?A low baseline blood neutrophil count and a high percentage of Treg among leucocytes are associated with an increased overall survival of recurrent high-grade glioma patients treated with Bevacizumab. Neuro Oncology

2016-10-01T16:21:08+02:00